Practice management and clinical software for autism and IDD care providers
CentralReach builds software for autism and IDD care providers, spanning scheduling, billing, clinical data collection and staff training. Its AWS, Kubernetes and Argo CD stack is now adding Datadog, Prometheus and Grafana, matching active projects around reliability and multi-environment observability. Accelerating, engineering-led hiring sits alongside customer-success pressure on renewals and churn.
CentralReach, founded in 2010 and headquartered in Fort Lauderdale, Florida, develops a software and services platform for organizations serving people with autism and related intellectual and developmental disabilities. Its products cover practice management, therapy scheduling, billing and payroll for ABA, speech, OT and PT providers, plus clinical data collection, HR and learning management. The privately held company employs 201–500 people and hires in the United States. It maintains SOC 2 and ISO 27001 compliance and runs on AWS with Snowflake for data.
CentralReach uses AWS, Kubernetes, Helm, Argo CD, Ruby on Rails, TypeScript, React, PostgreSQL, Snowflake, Salesforce and Splunk, and is adopting Datadog, Prometheus and Grafana.
Yes. Hiring is accelerating and weighted toward senior engineering roles, with additional openings in sales, support, data, security and marketing, all in the United States.
Current initiatives include reliability and observability tooling, AWS infrastructure automation, Snowflake deployment and secure connectivity, and cross-product adoption programs for customers.
Other companies in the same industry, closest in size
CentralReach's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →
This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.